No Data
No Data
TG Therapeutics Price Target Raised to $43 From $30 at JPMorgan
Express News | TG Therapeutics Inc : JP Morgan Raises Target Price to $43 From $30
A Closer Look at TG Therapeutics's Options Market Dynamics
TG Therapeutics Ranked Number One on Deloitte Technology Fast 500 for Rapid Growth in Biopharmaceutical Sector
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500
Reporters Tweets About 'Vague Whispers' of Bid Interest in TG Therapeutics